<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04759937</url>
  </required_header>
  <id_info>
    <org_study_id>Soh-Med-21-02-16</org_study_id>
    <nct_id>NCT04759937</nct_id>
  </id_info>
  <brief_title>Immunochromatography Versus Microscopy for Diagnosis of Entamoeba Histolytica/Dispar Infection.</brief_title>
  <official_title>Immunochromatography Versus Microscopy for Diagnosis of Entamoeba Histolytica/Dispar Infection in Sohag.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Amoebiasis, an infection by the protozoan parasite Entamoeba histolytica is globally&#xD;
      considered as the third leading parasitic cause of human mortality besides malaria and&#xD;
      schistosomiasis. It is estimated that E. histolytica may infect half a billion people&#xD;
      annually. Moreover, it was estimated that 100,000 patients per year died due to the clinical&#xD;
      complications of the disease. Laboratory diagnosis of E. histolytica/dispar is usually&#xD;
      achieved by microscopic detection of trophozoites or cysts in stool samples. Microscopy is&#xD;
      time consuming and requires an experienced observer to identify the organism. Furthermore, it&#xD;
      must be performed on three stool samples to increase sensitivity leading to decreased patient&#xD;
      compliance and delay in the final diagnosis. Therefore, a few the commercially available&#xD;
      copro-antigen assay have been developed for E. histolytica/dispar diagnosis including the&#xD;
      enzyme immunoassay and non-enzymatic immunochromatographic (ICT) assays that do not depend on&#xD;
      microscopy skills and increase laboratory efficiency by reducing time and cost.&#xD;
&#xD;
      The aim of the study is:&#xD;
&#xD;
        1. to evaluate the efficacy of commercially available rapid immunochromatographic&#xD;
           Copro-antigen assay (RIDAÂ® QUICK Entamoeba) in comparison with conventional microscopic&#xD;
           examination for the diagnosis of E. histolytica /dispar infection.&#xD;
&#xD;
        2. to estimate the prevalence of E. histolytica /dispar infection in outpatients in Sohag.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 20, 2021</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>evaluate the efficacy of immunochromatographic Copro-antigen assay for diagnosis of Entamoeba histolytica/ dispar.</measure>
    <time_frame>16 weeks following the startpoint of the study.</time_frame>
    <description>comparing the sensitivity and specifity with conventional microscopy for diagnosis of Entamoeba histolytica/ dispar infection.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>detect the prevelance of Entamoeba histolytica/ dispar in Sohag.</measure>
    <time_frame>16 weeks following the startpoint of the study.</time_frame>
    <description>By examining stool samples from 100 patients, the number of cases with Entamoena histolytica/dispar infection is recorded.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Dysentery Amebic</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      stool specimens&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        samples will be collected from outpatients complaining of dysentery or diarrhea with any&#xD;
        age &amp; sex groups from different locations (cities and village).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients complaining of dysentery or diarrhea with any age &amp; sex groups.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients taking amoebicidal drugs.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>khoulood Zakaria Hashem</last_name>
    <phone>01127936972</phone>
    <phone_ext>+20</phone_ext>
    <email>khoulood.zakaria@med.sohag.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of medicine-Sohag University</name>
      <address>
        <city>Sohag</city>
        <zip>093</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Khoulood Zakaria Hashem</last_name>
      <phone>01127936972</phone>
      <phone_ext>+20</phone_ext>
      <email>khoulood.zakaria@med.sohag.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>February 14, 2021</study_first_submitted>
  <study_first_submitted_qc>February 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2021</study_first_posted>
  <last_update_submitted>October 9, 2021</last_update_submitted>
  <last_update_submitted_qc>October 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Khoulood Zakaria Hashem</investigator_full_name>
    <investigator_title>Demonstrator at medical parasitology department, Faculty of medicine</investigator_title>
  </responsible_party>
  <keyword>dysentery</keyword>
  <keyword>diarrhea</keyword>
  <keyword>Entamoeba</keyword>
  <keyword>histolytica</keyword>
  <keyword>dispar</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dysentery</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>undecided</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

